Wednesday November 25 2009 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Guerbet LLC

Since 1901 Guerbet Group has had a long-standing tradition as a pioneer in the research and development of medical imaging contrast media. Headquartered in Paris, France, Guerbet is a publicly traded company holding more than 20% of the European market share and 7% of the worldwide contrast media market.
The Guerbet product portfolio is marketed in 130 countries worldwide and contains contrast agents for X-ray and MRI modalities: Oxilan®, Hexabrix®(1), Dotarem®(2), Lumirem®(2), Endorem®(2) and others. Guerbet dedicates the best talent and resources to new drug development, currently having multiple agents in Phase III clinical trials.

Guerbet LLC, the U.S. subsidiary was established in February of 2002 by purchasing the assets of Oxilan from Cook®, one of the leaders in the medical device industry. Currently Guerbet LLC is responsible for the marketing, sales and distribution of Oxilan® (Ioxilan Injection), a non-ionic contrast media for diagnostic and interventional imaging. In addition, steps are underway to seek approval for new products in the U.S. market, beginning with an extracellular MR agent and an MR blood pool agent in the future.


Contact Details:
1185 West 2nd Street
Bloomington
Indiana
47403-2160
United States of America
Tel:812-333-0059
Fax:812-333-0084
Email:info-us@guerbet-group.com
WWW:

www.guerbet-group.com/




Loading...

BioNews Results for Guerbet LLC:

Aerostar Capital and Presidio Global Team to Capitalize on Asian Aerospace Growth
PR Newswire:  Nov 23 2009 12:47AM Matching: llc
Microvision Shares Plunge as it Plans Stock offering
Research & Development:  Nov 22 2009 5:50AM Matching: llc
Ryogen is Awarded New Patent
Pharma Live:  Nov 21 2009 10:54AM Matching: llc
Pharmaceutical Manufacturer Fills Prescription for DEACOM ERP Software
TMC Net:  Nov 21 2009 9:27AM Matching: llc
XOMA (US) LLC (XOMA) Receives NASDAQ Determination Letter
BioSpace:  Nov 21 2009 12:37AM Matching: llc
Promote your company here: BioNewsCast - Press Release Distribution

View more Guerbet LLC news.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 338 times since April 2007, the link to the organisation's website has been followed 56 times

Recent Search Terms used to find this page: dotarem clinical trial guerbet | dotarem clinical trial guerbet | .

Search for more companies in Bloomington

Search for more companies in Indiana



This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Guerbet LLC

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.